Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1947 2
1948 2
1949 2
1951 3
1954 1
1956 2
1957 4
1958 1
1959 4
1961 1
1964 1
1984 1
1987 1
1989 1
1990 1
1991 2
1993 4
1994 1
1995 3
1996 1
1997 1
1998 4
1999 5
2000 7
2001 6
2002 7
2003 7
2004 4
2005 16
2006 15
2007 11
2008 15
2009 15
2010 18
2011 16
2012 16
2013 18
2014 12
2015 11
2016 13
2017 17
2018 18
2019 17
2020 11
2021 14
2022 9
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia.
Ettcheto M, Olloquequi J, Sánchez-López E, Busquets O, Cano A, Manzine PR, Beas-Zarate C, Castro-Torres RD, García ML, Bulló M, Auladell C, Folch J, Camins A. Ettcheto M, et al. Among authors: folch j. Front Aging Neurosci. 2020 Jan 8;11:344. doi: 10.3389/fnagi.2019.00344. eCollection 2019. Front Aging Neurosci. 2020. PMID: 31969812 Free PMC article.
Masitinib for the treatment of Alzheimer's disease.
Ettcheto M, Cano A, Sanchez-López E, Verdaguer E, Folch J, Auladell C, Camins A. Ettcheto M, et al. Among authors: folch j. Neurodegener Dis Manag. 2021 Aug;11(4):263-276. doi: 10.2217/nmt-2021-0019. Epub 2021 Aug 20. Neurodegener Dis Manag. 2021. PMID: 34412534 Review.
Involvement of JNK1 in Neuronal Polarization During Brain Development.
Castro-Torres RD, Busquets O, Parcerisas A, Verdaguer E, Olloquequi J, Ettcheto M, Beas-Zarate C, Folch J, Camins A, Auladell C. Castro-Torres RD, et al. Among authors: folch j. Cells. 2020 Aug 13;9(8):1897. doi: 10.3390/cells9081897. Cells. 2020. PMID: 32823764 Free PMC article. Review.
Impact of New Drugs for Therapeutic Intervention in Alzheimer's Disease.
Olloquequi J, Ettcheto M, Cano A, Sanchez-López E, Carrasco M, Espinosa T, Beas-Zarate C, Gudiño-Cabrera G, Ureña-Guerrero ME, Verdaguer E, Folch J, Auladell C, Camins A. Olloquequi J, et al. Among authors: folch j. Front Biosci (Landmark Ed). 2022 May 6;27(5):146. doi: 10.31083/j.fbl2705146. Front Biosci (Landmark Ed). 2022. PMID: 35638413 Free article. Review.
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease.
Camins A, Ettcheto M, Busquets O, Manzine PR, Castro-Torres RD, Beas-Zarate C, Verdaguer E, Sureda FX, Bulló M, Olloquequi J, Auladell C, Folch J. Camins A, et al. Among authors: folch j. Expert Opin Investig Drugs. 2019 Jan;28(1):93-97. doi: 10.1080/13543784.2019.1552677. Epub 2018 Dec 1. Expert Opin Investig Drugs. 2019. PMID: 30480461 No abstract available.
A metabolic perspective of late onset Alzheimer's disease.
Ettcheto M, Cano A, Busquets O, Manzine PR, Sánchez-López E, Castro-Torres RD, Beas-Zarate C, Verdaguer E, García ML, Olloquequi J, Auladell C, Folch J, Camins A. Ettcheto M, et al. Among authors: folch j. Pharmacol Res. 2019 Jul;145:104255. doi: 10.1016/j.phrs.2019.104255. Epub 2019 May 7. Pharmacol Res. 2019. PMID: 31075308 Free article. Review.
315 results